Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure
- PMID: 27326543
- PMCID: PMC4940265
- DOI: 10.1111/nyas.13099
Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure
Abstract
Exposure to the vesicating agents sulfur mustard (SM) and nitrogen mustard (NM) causes severe skin injury with delayed blistering. Depending upon the dose and time of their exposure, edema and erythema develop into blisters, ulceration, necrosis, desquamation, and pigmentation changes, which persist weeks and even years after exposure. Research advances have generated data that have started to explain the probable mechanism of action of vesicant-induced skin toxicity; however, despite these advances, effective and targeted therapies are still deficient. This review highlights studies on two SM analogs, 2-chloroethyl ethyl sulfide (CEES) and NM, and CEES- and NM-induced skin injury mouse models that have substantially added to the knowledge on the complex pathways involved in mustard vesicating agent-induced skin injury. Furthermore, employing these mouse models, studies under the National Institutes of Health Countermeasures Against Chemical Threats program have identified the flavanone silibinin as a novel therapeutic intervention with the potential to be developed as an effective countermeasure against skin injury following exposure to mustard vesicating agents.
Keywords: nitrogen mustard; silibinin; skin injury; sulfur mustard.
© 2016 New York Academy of Sciences.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Similar articles
-
Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.Toxicol Appl Pharmacol. 2015 May 15;285(1):71-8. doi: 10.1016/j.taap.2015.03.009. Epub 2015 Mar 16. Toxicol Appl Pharmacol. 2015. PMID: 25791923 Free PMC article.
-
Silibinin attenuates sulfur mustard analog-induced skin injury by targeting multiple pathways connecting oxidative stress and inflammation.PLoS One. 2012;7(9):e46149. doi: 10.1371/journal.pone.0046149. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029417 Free PMC article.
-
Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.Toxicol Appl Pharmacol. 2012 Oct 1;264(1):23-31. doi: 10.1016/j.taap.2012.07.014. Epub 2012 Jul 24. Toxicol Appl Pharmacol. 2012. PMID: 22841772 Free PMC article.
-
Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.Toxicol Sci. 2010 Mar;114(1):5-19. doi: 10.1093/toxsci/kfp253. Epub 2009 Oct 15. Toxicol Sci. 2010. PMID: 19833738 Free PMC article. Review.
-
Corneal toxicity induced by vesicating agents and effective treatment options.Ann N Y Acad Sci. 2016 Jun;1374(1):193-201. doi: 10.1111/nyas.13121. Epub 2016 Jun 21. Ann N Y Acad Sci. 2016. PMID: 27327041 Free PMC article. Review.
Cited by
-
Deciphering the role of microRNAs in mustard gas-induced toxicity.Ann N Y Acad Sci. 2021 May;1491(1):25-41. doi: 10.1111/nyas.14539. Epub 2020 Dec 10. Ann N Y Acad Sci. 2021. PMID: 33305460 Free PMC article. Review.
-
Oxidative Stress: An Intersection Between Radiation and Sulfur Mustard Lung Injury.Disaster Med Public Health Prep. 2024 May 6;18:e86. doi: 10.1017/dmp.2023.238. Disaster Med Public Health Prep. 2024. PMID: 38706344 Free PMC article.
-
A novel treatment for skin repair using a combination of spironolactone and vitamin D3.Ann N Y Acad Sci. 2020 Nov;1480(1):170-182. doi: 10.1111/nyas.14485. Epub 2020 Sep 6. Ann N Y Acad Sci. 2020. PMID: 32892377 Free PMC article.
-
Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models.J Pharmacol Exp Ther. 2024 Jan 17;388(2):536-545. doi: 10.1124/jpet.123.001718. J Pharmacol Exp Ther. 2024. PMID: 37652710 Free PMC article.
-
MG53 Mitigates Nitrogen Mustard-Induced Skin Injury.Cells. 2023 Jul 23;12(14):1915. doi: 10.3390/cells12141915. Cells. 2023. PMID: 37508578 Free PMC article.
References
-
- Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacological reviews. 1996;48:289–326. - PubMed
-
- Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol. 2005;19:297–315. - PubMed
-
- Ghabili K, et al. Mustard gas toxicity: the acute and chronic pathological effects. Journal of applied toxicology : JAT. 2010;30:627–643. - PubMed
-
- Ghabili K, et al. Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Critical reviews in toxicology. 2011;41:384–403. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources